Want to join the conversation?
$DVN reported a 3Q15 loss due to lower revenue and higher expenses. Net loss was $3.51Bil or $8.64 per share compared to a profit of $1.02Bil or $2.47 per share last year. Operating revenue dropped to $3.60Bil from $5.34Bil. Core earnings were $316MM or $0.76 per share for 3Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?